Although there are defined outpatient and inpatient spaces, when end of life occurs in the intensive care unit (ICU) setting, there is an opportunity for collaboration for chronic and acute medical teams to work for a “good death.”

In this commentary, we share our perspectives on collaborating for pulmonary hypertension patients as they approach end-of-life.

Current in vivo imaging techniques for cardiopulmonary vascular evaluation in Sprague-Dawley (SD) rats face limitations, including structural disruption, inadequate contrast filling, and invasiveness. This study developed a reliable, minimally invasive computed tomography angiography (CTA) technique via jugular vein catheterization for enhanced cardiopulmonary vascular imaging in live SD rats. 

This letter to the editor revisits the origins of high-dose calcium channel blocker use in pulmonary arterial hypertension (PAH) in light of bedside vasoreactivity testing, reaffirming its present-day relevance for a selected subgroup.

From the earliest days of human existence, people have inhabited some of the most challenging environments on Earth, including high-altitude regions. It is well established that chronic hypoxia, the defining environmental feature of mountainous areas, leads to high altitude-induced pulmonary hypertension (HAPH) in individuals who are not adequately adapted. Yet, despite the apparent presence of another environmental stressor, such as cold, its role in development remained overlooked for decades.

In 1999, I was asked by Pfizer to investigate the potential use of sildenafil, commonly known today as Viagra, for indications beyond its initial approval for erectile dysfunction. After conducting thorough research, I discovered studies published by the May and Baker pharmaceutical company that suggested a type 5 phosphodiesterase (PDE5) inhibitor could reduce pulmonary pressure in experimental animals [1-3].

My focus here is to tell the personal and historical story about the discovery and characterization of pulmonary hypertension caused by extreme cold, a condition now recognized as Northern Pulmonary Hypertension (NPH).

Platelets have emerged as immune-inflammatory cells that may contribute to the pathogenesis and prognosis of pulmonary arterial hypertension (PAH), although their clinical relevance remains uncertain.

Acute chest syndrome in sickle cell disease (SCD) carries high morbidity and mortality, with up to 15% of patients requiring invasive mechanical ventilation. However, the rates and mechanisms of ventilator-induced lung injury (VILI) in SCD remain poorly understood.

Access to infant cardiac surgery is inadequate in large parts of the globe. Consequently, there remains a persistent need for decision-making in children and adults with unoperated shunt lesions and varying pulmonary vascular resistance.

In the late 1940s, the US Air Force recorded an unacceptable number of crashes and emergency landings, prompting a formal enquiry. It was resolved that neither the engine nor the pilot was at fault. Attention turned instead to the design of the cockpit, which was based on the ‘average’ airman from 1926.